These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35131345)

  • 1. New Therapeutic Strategies Have Changed the Natural History of Pediatric Crohn's Disease: A Two-Decade Population-Based Study.
    Ley D; Leroyer A; Dupont C; Sarter H; Bertrand V; Spyckerelle C; Guillon N; Wils P; Savoye G; Turck D; Gower-Rousseau C; Fumery M;
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2588-2597.e1. PubMed ID: 35131345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Therapeutic Strategies Are Associated With a Significant Decrease in Colectomy Rate in Pediatric Ulcerative Colitis.
    Ley D; Leroyer A; Dupont C; Sarter H; Bertrand V; Spyckerelle C; Guillon N; Wils P; Savoye G; Turck D; Gower-Rousseau C; Fumery M;
    Am J Gastroenterol; 2023 Nov; 118(11):1997-2004. PubMed ID: 37141541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
    Cernoch PS; Fournier N; Zeitz J; Scharl M; Morell B; Greuter T; Schreiner P; Misselwitz B; Safroneeva E; Schoepfer AM; Vavricka SR; Rogler G; Biedermann L;
    Dig Dis Sci; 2020 Sep; 65(9):2654-2663. PubMed ID: 31797187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Anal Ulcerations in Pediatric-Onset Crohn's Disease: Long-Term Follow-Up of a Population-Based Study.
    Mortreux P; Leroyer A; Dupont C; Ley D; Bertrand V; Spyckerelle C; Guillon N; Wils P; Gower-Rousseau C; Savoye G; Fumery M; Turck D; Siproudhis L; Sarter H
    Am J Gastroenterol; 2023 Sep; 118(9):1671-1678. PubMed ID: 37104674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the Long-term Prognosis of Crohn's Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study.
    Ye BD; Hong SN; Seo SI; Kim YJ; Cha JM; Rhee KH; Yoon H; Kim YH; Kim KH; Park SY; Jeong SK; Lee JH; Park H; Kim JS; Im JP; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Park SH; Yang SK;
    Gut Liver; 2022 Mar; 16(2):216-227. PubMed ID: 34148870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of medical therapy on patients with Crohn's disease requiring surgical resection.
    Fu YT; Hong T; Round A; Bressler B
    World J Gastroenterol; 2014 Sep; 20(33):11808-14. PubMed ID: 25206286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study.
    Fumery M; Pariente B; Sarter H; Savoye G; Spyckerelle C; Djeddi D; Mouterde O; Bouguen G; Ley D; Peneau A; Dupas JL; Turck D; Gower-Rousseau C;
    Dig Liver Dis; 2019 Apr; 51(4):496-502. PubMed ID: 30611597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing face of Crohn's disease: a population-based study of the natural history of Crohn's disease in Örebro, Sweden 1963-2005.
    Zhulina Y; Udumyan R; Tysk C; Montgomery S; Halfvarson J
    Scand J Gastroenterol; 2016 Mar; 51(3):304-13. PubMed ID: 26448101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of children with mild Crohn's disease.
    Sharma Y; Bousvaros A; Liu E; Bender Stern J
    World J Gastroenterol; 2019 Aug; 25(30):4235-4245. PubMed ID: 31435176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.
    Rinawi F; Assa A; Hartman C; Mozer Glassberg Y; Friedler VN; Rosenbach Y; Silbermintz A; Zevit N; Shamir R
    Inflamm Bowel Dis; 2016 Dec; 22(12):2917-2923. PubMed ID: 27755214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset versus late-onset Crohn's disease: An Italian cohort study.
    Cantoro L; Lenti MV; Monterubbianesi R; Cicala M; Giannarelli D; Papi C; Kohn A; Di Sabatino A
    United European Gastroenterol J; 2020 Feb; 8(1):52-58. PubMed ID: 32213053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
    Rodríguez-Lago I; Hoyo JD; Pérez-Girbés A; Garrido-Marín A; Casanova MJ; Chaparro M; Fernández-Clotet A; Castro-Poceiro J; García MJ; Sánchez S; Ferreiro-Iglesias R; Bastón I; Piqueras M; Careda LEIB; Mena R; Suárez C; Cordón JP; López-García A; Márquez L; Arroyo M; Alfambra E; Sierra M; Cano N; Delgado-Guillena P; Morales-Alvarado V; Aparicio JC; Guerra I; Aulló C; Merino O; Arranz L; Hidalgo MA; Llaó J; Plaza R; Molina G; Torres P; Pérez-Galindo P; Romero MG; Herrera-deGuise C; Armesto E; Mesonero F; Frago-Larramona S; Benítez JM; Calvo M; Martín MDCL; Elorza A; Larena A; Peña E; Rodríguez-Grau MDC; Miguel-Criado J; Botella B; Olmos JA; López L; Aguirre U; Gisbert JP;
    United European Gastroenterol J; 2020 Nov; 8(9):1056-1066. PubMed ID: 32723069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type.
    Nagata Y; Esaki M; Moriyama T; Hirano A; Umeno J; Maehata Y; Torisu T; Matsumoto T; Kitazono T
    J Gastroenterol; 2019 Apr; 54(4):330-338. PubMed ID: 30244398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Long-Term Outcomes of Paediatric Crohn's Disease: A Single-Centre Experience.
    Kim HJ; Oh SH; Kim DY; Lee HS; Park SH; Yang SK; Kim KM
    J Crohns Colitis; 2017 Feb; 11(2):157-164. PubMed ID: 27651220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies.
    Pauwels RWM; van der Woude CJ; Nieboer D; Steyerberg EW; Casanova MJ; Gisbert JP; Kennedy NA; Lees CW; Louis E; Molnár T; Szántó K; Leo E; Bots S; Downey R; Lukas M; Lin WC; Amiot A; Lu C; Roblin X; Farkas K; Seidelin JB; Duijvestein M; D'Haens GR; de Vries AC;
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1671-1686.e16. PubMed ID: 33933376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I; Faubion WA
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn's disease.
    Vuyyuru SK; Kante B; Kumar P; Sahu P; Kedia S; Ranjan MK; Sharma R; Panwar R; Makharia G; Ahuja V
    Sci Rep; 2021 Jun; 11(1):11704. PubMed ID: 34083575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
    Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
    Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.